The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
The Restriction Factors of Human Immunodeficiency Virus
Open accessAbstract
Cellular proteins called "restriction factors" can serve as powerful blockades to HIV replication, but the virus possesses elaborate strategies to circumvent these barriers. First, we discuss general hallmarks of a restriction factor. Second, we review how the viral Vif protein protects the viral genome from lethal levels of cDNA deamination by promoting APOBEC3 protein degradation; how the viral Vpu, Env, and Nef proteins facilitate internalization and degradation of the virus-tethering protein BST-2/tetherin; and how the viral Vpx protein prevents the premature termination of reverse transcription by degrading the dNTPase SAMHD1. These HIV restriction and counter-restriction mechanisms suggest strategies for new therapeutic interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
Sheehy, A. M., Gaddis, N. C., Choi, J. D., & Malim, M. H. (2002) · Nature · doi:10.1038/nature00939 · Cited by 2,327
Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu
Neil, S. J. D., Zang, T., & Bieniasz, P. D. (2008) · Nature · doi:10.1038/nature06553 · Cited by 1,902
The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys
Stremlau, M., Owens, C. M., Perron, M. J., Kiessling, M., Autissier, P., & Sodroski, J. (2004) · Nature · doi:10.1038/nature02343 · Cited by 1,816
Importance of the nef gene for maintenance of high virus loads and for development of AIDS
Kestier, H. W., Ringler, D. J., Mori, K., Panicali, D. L., Sehgal, P. K., Daniel, M. D., & Desrosiers, R. C. (1991) · Cell · doi:10.1016/0092-8674(91)90097-i · Cited by 1,596
SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx
Laguette, N., Sobhian, B., Casartelli, N., Ringeard, M., Chable-Bessia, C., Ségéral, E., Yatim, A., Emiliani, S., Schwartz, O., & Benkirane, M. (2011) · Nature · doi:10.1038/nature10117 · Cited by 1,511 · cited 2×
“Vpx serves as a scaffold for the formation of an E3 ubiquitin ligase complex consisting of DCAF1, DDB1, and CUL4, which combine to promote the polyubiquitination and degradation of SAMHD1 (79, 80, 86).”
BackgroundBroad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts
Mangeat, B., Turelli, P., Caron, G., Friedli, M., Perrin, L., & Trono, D. (2003) · Nature · doi:10.1038/nature01709 · Cited by 1,486
DNA Deamination Mediates Innate Immunity to Retroviral Infection
Harris, R. S., Bishop, K. N., Sheehy, A. M., Craig, H. M., Petersen-Mahrt, S. K., Watt, I. N., Neuberger, M. S., & Malim, M. H. (2003) · Cell · doi:10.1016/s0092-8674(03)00423-9 · Cited by 1,266
Self-citationVpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein
Hrecka, K., Hao, C., Gierszewska, M., Swanson, S. K., Kesik-Brodacka, M., Srivastava, S., Florens, L., Washburn, M. P., & Skowronski, J. (2011) · Nature · doi:10.1038/nature10195 · Cited by 1,200 · cited 2×
“Vpx serves as a scaffold for the formation of an E3 ubiquitin ligase complex consisting of DCAF1, DDB1, and CUL4, which combine to promote the polyubiquitination and degradation of SAMHD1 (79, 80, 86).”
BackgroundInduction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex
Yu, X., Yu, Y., Liu, B., Luo, K., Kong, W., Mao, P., & Yu, X.-F. (2003) · Science · doi:10.1126/science.1089591 · Cited by 1,200
The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA
Zhang, H., Yang, B., Pomerantz, R. J., Zhang, C., Arunachalam, S. C., & Gao, L. (2003) · Nature · doi:10.1038/nature01707 · Cited by 1,059
Van Damme, N., Goff, D., Katsura, C., Jorgenson, R. L., Mitchell, R., Johnson, M. C., Stephens, E. B., & Guatelli, J. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.03.001 · Cited by 1,050
Lahouassa, H., Daddacha, W., Hofmann, H., Ayinde, D., Logue, E. C., Dragin, L., Bloch, N., Maudet, C., Bertrand, M., Gramberg, T., et al. (2012) · Nature Immunology · doi:10.1038/ni.2236 · Cited by 852
HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase
Goldstone, D. C., Ennis-Adeniran, V., Hedden, J. J., Groom, H. C. T., Rice, G. I., Christodoulou, E., Walker, P. A., Kelly, G., Haire, L. F., Yap, M. W., et al. (2011) · Nature · doi:10.1038/nature10623 · Cited by 831
RNA Editing Enzyme APOBEC1 and Some of Its Homologs Can Act as DNA Mutators
Harris, R. S., Petersen-Mahrt, S. K., & Neuberger, M. S. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00742-6 · Cited by 603
Self-citationSingle-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome
Yu, Q., König, R., Pillai, S., Chiles, K., Kearney, M., Palmer, S., Richman, D., Coffin, J. M., & Landau, N. R. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb758 · Cited by 597
Tetherin Inhibits HIV-1 Release by Directly Tethering Virions to Cells
Perez-Caballero, D., Zang, T., Ebrahimi, A., McNatt, M. W., Gregory, D. A., Johnson, M. C., & Bieniasz, P. D. (2009) · Cell · doi:10.1016/j.cell.2009.08.039 · Cited by 595
HIV-1 Accessory Proteins—Ensuring Viral Survival in a Hostile Environment
Malim, M. H., & Emerman, M. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.04.008 · Cited by 551
Miller, M. D., Warmerdam, M. T., Gaston, I., Greene, W. C., & Feinberg, M. B. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.1.101 · Cited by 527
The HIV A (sor) gene product is essential for virus infectivity
Strebel, K., Daugherty, D., Clouse, K., Cohen, D., Folks, T., & Martin, M. A. (1987) · Nature · doi:10.1038/328728a0 · Cited by 479
A Novel Gene of HIV-1, vpu , and Its 16-Kilodalton Product
Strebel, K., Klimkait, T., & Martin, M. A. (1988) · Science · doi:10.1126/science.3261888 · Cited by 447
Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes
Gabuzda, D. H., Lawrence, K., Langhoff, E., Terwilliger, E., Dorfman, T., Haseltine, W. A., & Sodroski, J. (1992) · Journal of Virology · doi:10.1128/jvi.66.11.6489-6495.1992 · Cited by 446
Bst‐2/HM1.24 Is a Raft‐Associated Apical Membrane Protein with an Unusual Topology
Kupzig, S., Korolchuk, V., Rollason, R., Sugden, A., Wilde, A., & Banting, G. (2003) · Traffic · doi:10.1034/j.1600-0854.2003.00129.x · Cited by 430
Sauter, D., Schindler, M., Specht, A., Landford, W. N., Münch, J., Kim, K.-A., Votteler, J., Schubert, U., Bibollet-Ruche, F., Keele, B. F., et al. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.10.004 · Cited by 429
A Single Amino Acid Change in the SPRY Domain of Human Trim5α Leads to HIV-1 Restriction
Yap, M. W., Nisole, S., & Stoye, J. P. (2005) · Current Biology · doi:10.1016/j.cub.2004.12.042 · Cited by 408
Species-Specific Activity of SIV Nef and HIV-1 Vpu in Overcoming Restriction by Tetherin/BST2
Jia, B., Serra-Moreno, R., Neidermyer, W., Rahmberg, A., Mackey, J., Fofana, I. B., Johnson, W. E., Westmoreland, S., & Evans, D. T. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000429 · Cited by 406
Self-citationNef stimulates human immunodeficiency virus type 1 proviral DNA synthesis
Aiken, C., & Trono, D. (1995) · Journal of Virology · doi:10.1128/jvi.69.8.5048-5056.1995 · Cited by 385
Nef Proteins from Simian Immunodeficiency Viruses Are Tetherin Antagonists
Zhang, F., Wilson, S. J., Landford, W. C., Virgen, B., Gregory, D., Johnson, M. C., Munch, J., Kirchhoff, F., Bieniasz, P. D., & Hatziioannou, T. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.05.008 · Cited by 355
Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection
Jäger, S., Kim, D. Y., Hultquist, J. F., Shindo, K., LaRue, R. S., Kwon, E., Li, M., Anderson, B. D., Yen, L., Stanley, D., et al. (2012) · Nature · doi:10.1038/nature10693 · Cited by 352 · cited 3×
“Recent proteomic studies identified the transcription factor Core Binding Factor b (CBF ) as a Vif-associated protein that also associates with the E3 ligase but only in the presence of Vif (27, 28).”
BackgroundSelf-citationDouglas, J. L., Viswanathan, K., McCarroll, M. N., Gustin, J. K., Früh, K., & Moses, A. V. (2009) · Journal of Virology · doi:10.1128/jvi.00242-09 · Cited by 344
Powell, R. D., Holland, P. J., Hollis, T., & Perrino, F. W. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.c111.317628 · Cited by 344
Selection, recombination, and G----A hypermutation of human immunodeficiency virus type 1 genomes
Vartanian, J. P., Meyerhans, A., Asjö, B., & Wain-Hobson, S. (1991) · Journal of Virology · doi:10.1128/jvi.65.4.1779-1788.1991 · Cited by 341
Hultquist, J. F., Lengyel, J. A., Refsland, E. W., LaRue, R. S., Lackey, L., Brown, W. L., & Harris, R. S. (2011) · Journal of Virology · doi:10.1128/jvi.05238-11 · Cited by 338
Self-citationMitchell, R. S., Katsura, C., Skasko, M. A., Fitzpatrick, K., Lau, D., Ruiz, A., Stephens, E. B., Margottin-Goguet, F., Benarous, R., & Guatelli, J. C. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000450 · Cited by 326
Mangeat, B., Gers-Huber, G., Lehmann, M., Zufferey, M., Luban, J., & Piguet, V. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000574 · Cited by 309
APOBEC3G DNA deaminase acts processively 3′ → 5′ on single-stranded DNA
Chelico, L., Pham, P., Calabrese, P., & Goodman, M. F. (2006) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1086 · Cited by 306
Mehle, A., Goncalves, J., Santa-Marta, M., McPike, M., & Gabuzda, D. (2004) · Genes & Development · doi:10.1101/gad.1249904 · Cited by 296
Evidence for a newly discovered cellular anti-HIV-1 phenotype
Simon, J. H. M., Gaddis, N. C., Fouchier, R. A. M., & Malim, M. H. (1998) · Nature Medicine · doi:10.1038/3987 · Cited by 280
Le Tortorec, A., & Neil, S. J. D. (2009) · Journal of Virology · doi:10.1128/jvi.01515-09 · Cited by 280
Neil, S. J. D., Eastman, S. W., Jouvenet, N., & Bieniasz, P. D. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020039 · Cited by 276
Neil, S. J. D., Sandrin, V., Sundquist, W. I., & Bieniasz, P. D. (2007) · Cell Host & Microbe · doi:10.1016/j.chom.2007.08.001 · Cited by 275
T-cell differentiation factor CBF-β regulates HIV-1 Vif-mediated evasion of host restriction
Zhang, W., Du, J., Evans, S. L., Yu, Y., & Yu, X.-F. (2012) · Nature · doi:10.1038/nature10718 · Cited by 264
Lim, E. S., Fregoso, O. I., McCoy, C. O., Matsen, F. A., Malik, H. S., & Emerman, M. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.01.004 · Cited by 261
Iwabu, Y., Fujita, H., Kinomoto, M., Kaneko, K., Ishizaka, Y., Tanaka, Y., Sata, T., & Tokunaga, K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.058305 · Cited by 238
Nègre, D., Mangeot, P.-E., Duisit, G., Blanchard, S., Vidalain, P.-O., Leissner, P., Winter, A.-J., Rabourdin-Combe, C., Mehtali, M., Moullier, P., et al. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301292 · Cited by 206
Goujon, C., Rivière, L., Jarrosson-Wuilleme, L., Bernaud, J., Rigal, D., Darlix, J.-L., & Cimarelli, A. (2007) · Retrovirology · doi:10.1186/1742-4690-4-2 · Cited by 205
Kim, B., Nguyen, L. A., Daddacha, W., & Hollenbaugh, J. A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.c112.374843 · Cited by 204
Antiretroelement Activity of APOBEC3H Was Lost Twice in Recent Human Evolution
OhAinle, M., Kerns, J. A., Li, M. M. H., Malik, H. S., & Emerman, M. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.07.005 · Cited by 204
Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics
Albin, J. S., & Harris, R. S. (2010) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409001343 · Cited by 186
Self-citationAhn, J., Hao, C., Yan, J., DeLucia, M., Mehrens, J., Wang, C., Gronenborn, A. M., & Skowronski, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.340711 · Cited by 184
Mutation of a Single Residue Renders Human Tetherin Resistant to HIV-1 Vpu-Mediated Depletion
Gupta, R. K., Hué, S., Schaller, T., Verschoor, E., Pillay, D., & Towers, G. J. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000443 · Cited by 180
Janini, M., Rogers, M., Birx, D. R., & McCutchan, F. E. (2001) · Journal of Virology · doi:10.1128/jvi.75.17.7973-7986.2001 · Cited by 175
Laguette, N., Rahm, N., Sobhian, B., Chable-Bessia, C., Münch, J., Snoeck, J., Sauter, D., Switzer, W. M., Heneine, W., Kirchhoff, F., et al. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.01.007 · Cited by 174
Viral protein U counteracts a human host cell restriction that inhibits HIV-1 particle production
Varthakavi, V., Smith, R. M., Bour, S. P., Strebel, K., & Spearman, P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2433165100 · Cited by 167
HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment
Hauser, H., Lopez, L. A., Yang, S. J., Oldenburg, J. E., Exline, C. M., Guatelli, J. C., & Cannon, P. M. (2010) · Retrovirology · doi:10.1186/1742-4690-7-51 · Cited by 163
Gupta, R. K., Mlcochova, P., Pelchen-Matthews, A., Petit, S. J., Mattiuzzo, G., Pillay, D., Takeuchi, Y., Marsh, M., & Towers, G. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907075106 · Cited by 160
Goujon, C., Arfi, V., Pertel, T., Luban, J., Lienard, J., Rigal, D., Darlix, J., & Cimarelli, A. (2008) · Journal of Virology · doi:10.1128/jvi.01181-08 · Cited by 159
Li, Y., Xing, L., Stremlau, M. H., Lee, M. N., & Sodroski, J. (2006) · Journal of Virology · doi:10.1128/jvi.00270-06 · Cited by 153
Hammonds, J. E., Wang, J.-J., Yi, H. L., & Spearman, P. W. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000749 · Cited by 150
Miyagi, E., Opi, S., Takeuchi, H., Khan, M. H., Goila-Gaur, R., Kao, S., & Strebel, K. (2007) · Journal of Virology · doi:10.1128/jvi.01361-07 · Cited by 150
Schumacher, A. J., Haché, G., MacDuff, D. A., Brown, W. L., & Harris, R. S. (2008) · Journal of Virology · doi:10.1128/jvi.02391-07 · Cited by 148
Self-citationThe ESCRT-0 Component HRS is Required for HIV-1 Vpu-Mediated BST-2/Tetherin Down-Regulation
Janvier, K., Pelchen–Matthews, A., Renaud, J.-B., Caillet, M., Marsh, M., & Berlioz‐Torrent, C. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001265 · Cited by 133
Analysis of Human APOBEC3H Haplotypes and Anti-Human Immunodeficiency Virus Type 1 Activity
Wang, X., Abudu, A., Son, S., Dang, Y., Venta, P. J., & Zheng, Y. (2011) · Journal of Virology · doi:10.1128/jvi.02049-10 · Cited by 126
Rong, L., Zhang, J., Lu, J., Pan, Q., Lorgeoux, R.-P., Aloysius, C., Guo, F., Liu, S., Wainberg, M. A., & Liang, C. (2009) · Journal of Virology · doi:10.1128/jvi.00620-09 · Cited by 125
Restriction of HIV-1 by APOBEC3G is cytidine deaminase-dependent
Browne, E. P., Allers, C., & Landau, N. R. (2009) · Virology · doi:10.1016/j.virol.2009.02.026 · Cited by 121
Yu, X. F., Yu, Q., Essex, M., & Lee, T. H. (1991) · Journal of Virology · doi:10.1128/jvi.65.9.5088-5091.1991 · Cited by 120
Guyader, M., Emerman, M., Montagnier, L., & Peden, K. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03488.x · Cited by 118
Lopez, L. A., Yang, S. J., Hauser, H., Exline, C. M., Haworth, K. G., Oldenburg, J. E., & Cannon, P. M. (2010) · Journal of Virology · doi:10.1128/jvi.02636-09 · Cited by 111
Kaushik, R., Zhu, X., Stránská, R., Wu, Y., & Stevenson, M. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.05.022 · Cited by 109
Compton, A. A., Hirsch, V. M., & Emerman, M. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2011.11.010 · Cited by 107
LaRue, R. S., Lengyel, J., Jönsson, S., Andrésdóttir, V., & Harris, R. S. (2010) · Journal of Virology · doi:10.1128/jvi.00685-10 · Cited by 104
Self-citationRefsland, E. W., Hultquist, J. F., & Harris, R. S. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002800 · Cited by 99
Self-citationBCA2/Rabring7 Promotes Tetherin-Dependent HIV-1 Restriction
Miyakawa, K., Ryo, A., Murakami, T., Ohba, K., Yamaoka, S., Fukuda, M., Guatelli, J., & Yamamoto, N. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000700 · Cited by 99
Bour, S. P., Schubert, U., Peden, K., & Strebel, K. (1996) · Journal of Virology · doi:10.1128/jvi.70.2.820-829.1996 · Cited by 96
Hiding in Plain Sight: How HIV Evades Innate Immune Responses
Manel, N., & Littman, D. R. (2011) · Cell · doi:10.1016/j.cell.2011.09.010 · Cited by 95
Serra-Moreno, R., Jia, B., Breed, M. W., Alvarez, X. A., & Evans, D. T. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2010.12.005 · Cited by 92
Self-citationSchmidt, S., Fritz, J. V., Bitzegeio, J., Fackler, O., & Keppler, O. T. (2011) · mBio · doi:10.1128/mbio.00036-11 · Cited by 92
Pillai, S. K., Wong, J. K., & Barbour, J. D. (2008) · Retrovirology · doi:10.1186/1742-4690-5-26 · Cited by 88
Kobayashi, T., Ode, H., Yoshida, T., Sato, K., Gee, P., Yamamoto, S. P., Ebina, H., Strebel, K., Sato, H., & Koyanagi, Y. (2010) · Journal of Virology · doi:10.1128/jvi.01668-10 · Cited by 79
Rab7A Is Required for Efficient Production of Infectious HIV-1
Caillet, M., Janvier, K., Pelchen–Matthews, A., Delcroix-Genête, D., Camus, G., Marsh, M., & Berlioz‐Torrent, C. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002347 · Cited by 74
Wei, W., Guo, H., Han, X., Liu, X., Zhou, X., Zhang, W., & Yu, X.-F. (2012) · Cellular Microbiology · doi:10.1111/j.1462-5822.2012.01835.x · Cited by 73
SIV Nef Proteins Recruit the AP-2 Complex to Antagonize Tetherin and Facilitate Virion Release
Zhang, F., Landford, W. N., Ng, M., McNatt, M. W., Bieniasz, P. D., & Hatziioannou, T. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002039 · Cited by 70
Human immunodeficiency virus type 2 vpx protein augments viral infectivity
Kappes, J. C., Conway, J. A., Lee, S.-W., Shaw, G. M., & Hahn, B. H. (1991) · Virology · doi:10.1016/0042-6822(91)90836-z · Cited by 67
Albin, J. S., Haché, G., Hultquist, J. F., Brown, W. L., & Harris, R. S. (2010) · Journal of Virology · doi:10.1128/jvi.00632-10 · Cited by 50
Self-citationEnhancing immunity to HIV through APOBEC
Harris, R. S. (2008) · Nature Biotechnology · doi:10.1038/nbt1008-1089 · Cited by 48
Self-citationThe functions of the HIV1 protein Vpr and its action through the DCAF1·DDB1·Cullin4 ubiquitin ligase
Casey, L., Wen, X., & de Noronha, C. M. C. (2010) · Cytokine · doi:10.1016/j.cyto.2010.02.018 · Cited by 44
Vorontsov, I. I., Minasov, G., Kiryukhina, O., Brunzelle, J. S., Shuvalova, L., & Anderson, W. F. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.250456 · Cited by 42
Zhang, C., de Silva, S., Wang, J., & Wu, L. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037477 · Cited by 42
Gustin, J. K., Douglas, J. L., Bai, Y., & Moses, A. V. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.349928 · Cited by 40
Haché, G., Abbink, T. E. M., Berkhout, B., & Harris, R. S. (2009) · Journal of Virology · doi:10.1128/jvi.00045-09 · Cited by 27
Self-citationThe role of tripartite motif family members in mediating susceptibility to HIV-1 infection
Rahm, N., & Telenti, A. (2012) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32835048e1 · Cited by 23
Cited by
Evidence for APOBEC3B mutagenesis in multiple human cancers
Burns, M. B., Temiz, N. A., & Harris, R. S. (2013) · Nature Genetics · doi:10.1038/ng.2701 · Cited by 755
Self-citationHarris, R. S., & Dudley, J. P. (2015) · Virology · doi:10.1016/j.virol.2015.03.012 · Cited by 551
Self-citationPhosphorylation of SAMHD1 by Cyclin A2/CDK1 Regulates Its Restriction Activity toward HIV-1
Cribier, A., Descours, B., Valadão, A. L. C., Laguette, N., & Benkirane, M. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.03.017 · Cited by 370
Constitutive immune mechanisms: mediators of host defence and immune regulation
Paludan, S. R., Pradeu, T., Masters, S. L., & Mogensen, T. H. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-0391-5 · Cited by 362
Guanylate Binding Protein (GBP) 5 Is an Interferon-Inducible Inhibitor of HIV-1 Infectivity
Krapp, C., Hotter, D., Gawanbacht, A., McLaren, P. J., Kluge, S. F., Stürzel, C. M., Mack, K., Reith, E., Engelhart, S., Ciuffi, A., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.02.019 · Cited by 256
Metadata
- Authors
- Harris, R. S., Hultquist, J. F., & Evans, D. T.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2012-11
- Volume
- 287
- Issue
- 49
- Pages
- 40875-40883
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2152327707
- Cited by
- 287
- References
- 90
- FWCI
- 14.75
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.